80 related articles for article (PubMed ID: 11565505)
61. Influence of perftoran on structural and metabolic disturbances in the liver during experimental atherosclerosis.
Leskova GF; Michunskaya AB; Kobozeva LP; Klimenko ED
Bull Exp Biol Med; 2003 Oct; 136(4):340-3. PubMed ID: 14714077
[TBL] [Abstract][Full Text] [Related]
62. [Membrane-stabilizing effect of phospholipid liposomes in toxic hepatitis].
Akhundzhanova LL; Aripov OA; Khalimbetov GS
Klin Lab Diagn; 2002 Jun; (6):52-3. PubMed ID: 12132382
[No Abstract] [Full Text] [Related]
63. Activity of sphingomyelinase in rat liver in acute and chronic toxic hepatitis: proportion between peroxidative and phospholipase pathways of lipid bilayer modification.
Serebrov VY; Kuzmenko DI; Burov PG; Novitsky SV
Bull Exp Biol Med; 2009 Jan; 147(1):36-8. PubMed ID: 19526125
[TBL] [Abstract][Full Text] [Related]
64. [Effect of perftoran on the oxidant-antioxidant system in patients with severe trauma and blood loss].
Ostapchenko DA; Radaev SM; Gerasimov LV; Nemtsova ER; Sergeeva TV; Vlasenko AV
Anesteziol Reanimatol; 2003; (6):13-5. PubMed ID: 14991970
[TBL] [Abstract][Full Text] [Related]
65. Resolution of microheterogeneous forms of glucose-6-phosphate dehydrogenase by electrophoresis on cellulose acetate.
Watanabe A; Taketa K
Enzyme; 1971; 12(6):694-8. PubMed ID: 5154448
[No Abstract] [Full Text] [Related]
66. Behavior of the protein-bound dye, N-demethylase, catalase and xanthine oxidase activites of rat liver during the course of repeated administrations of 3'-Me-DAB.
MATSUMOTO M; YAMADA T; TERAYAMA H
Gan; 1960 Sep; 51():255-64. PubMed ID: 13768228
[No Abstract] [Full Text] [Related]
67. [Zeolite-containing tripoli powder in experimental hepatology].
Kolotilova ML; Ivanov LN
Patol Fiziol Eksp Ter; 2005; (3):12-3. PubMed ID: 16206521
[TBL] [Abstract][Full Text] [Related]
68. Xanthine oxidase-derived reactive oxygen species contribute to the development of D-galactosamine-induced liver injury in rats.
Ohta Y; Matsura T; Kitagawa A; Tokunaga K; Yamada K
Free Radic Res; 2007 Feb; 41(2):135-44. PubMed ID: 17364939
[TBL] [Abstract][Full Text] [Related]
69. [The effect of perftoran on the biochemical detoxication parameters in rats with an acute toxic lesion of the liver].
Inoiatov FSh
Eksp Klin Farmakol; 2000; 63(2):67-70. PubMed ID: 10834100
[TBL] [Abstract][Full Text] [Related]
70. Glutathione-S-transferase, superoxide dismutase, xanthine oxidase, catalase, glutathione peroxidase and lipid peroxidation in the liver of exercised rats.
Vani M; Reddy GP; Reddy GR; Thyagaraju K; Reddanna P
Biochem Int; 1990; 21(1):17-26. PubMed ID: 2386536
[TBL] [Abstract][Full Text] [Related]
71. Effects of diallyl tetrasulfide on cadmium-induced oxidative damage in the liver of rats.
Murugavel P; Pari L
Hum Exp Toxicol; 2007 Jun; 26(6):527-34. PubMed ID: 17698948
[TBL] [Abstract][Full Text] [Related]
72. [Effect of treatment with perftoran on the course of experimental uveitis, lipid peroxidation and activity of antioxidant defense enzymes].
Karimova MKh; Inoiatova FKh
Vopr Med Khim; 2002; 48(5):450-4. PubMed ID: 12498086
[TBL] [Abstract][Full Text] [Related]
73. [Effect of perftoran on experimental hepatitis].
Kovelenov AIu; Lobzin IuV; Pluzhnikova NN; D'iachkov DG
Eksp Klin Farmakol; 2001; 64(3):41-4. PubMed ID: 11565505
[TBL] [Abstract][Full Text] [Related]
74.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
75.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
76.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
77.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
78.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
